March 1, 2021 20:38

CEO of Medical Device Company Charged in COVID-19 Related Securities Fraud Scheme

The chief executive officer (CEO) of a California-based medical device company was indicted by a federal grand jury in connection with an alleged scheme to defraud investors by making false and misleading statements about the purported development of a new COVID-19 test, leading to millions of dollars in investor losses.

Leave a Comment

Your email address will not be published. Required fields are marked *

Scroll to Top